TechLab - Pharos

Company Profile

FUND

Pharos III

Status

Year of Investment

2016

location

Blacksburg, VA

sector

Diagnostics / Infectious Disease

strategic focus

Rapid intestinal diagnostic testing (C. difficile, parasitology, inflammation markers)

During our time of ownership, TechLab, headquartered in Blacksburg,VA, was a leading developer and manufacturer of intestinal diagnostics products in the United States. Founded in 1989, the company had a state-of-the-art manufacturing facility in Radford, VA. TechLab's patented QUIK CHEK® rapid tests delivered extremely accurate results in 30 minutes. The Company had a market-leading portfolio of diagnostic tests for intestinal diseases, including C. difficile (C. Diff) bacteria, parasitology, and inflammation.

*Disclaimer: These descriptions refer to the company during our time of ownership.

Other Companies in Our Portfolio

Outpatient Rehab / Physical and Occupational Therapy

Pharos III

MOTION PT Group

Outpatient provider of physical therapy and occupational therapy services.

Realized investment. Northeast outpatient rehab platform spanning orthopedics, neurology, pediatrics, and specialty therapy disciplines

LEARN MORE

Behavioral Health / Inpatient and Outpatient Psychiatry

Pharos III

Seaside Healthcare

Mental health treatment services for the adolescent, adult, and geriatric population.

Realized per the portfolio filter (individual page still displays "Current"). Full continuum of inpatient, outpatient, and community mental health services

LEARN MORE

Diagnostics / Cardiometabolic

Pharos I

Atherotech, Inc.

Cardiometabolic testing and disease management solutions.

Previous investment. Diagnostic company commercializing VAP cholesterol testing for cardiovascular disease risk.

LEARN MORE

Medical Devices / Remote Patient Monitoring

Pharos IV

RhythMedix

Cardiac remote patient monitoring.

Active investment, advancing wearable cardiac monitoring technology for faster arrhythmia detection

LEARN MORE

Three Ways to Work with Pharos

Whether you're allocating capital or building a healthcare company, we start with the same question: does this serve the communities that need it most?

Investors

Pharos partners with foundations, family offices, and institutional investors who want competitive returns from healthcare companies serving underserved communities.

Contact Investor Relations

Founders & Operators

We invest $25 to $50 million in established, U.S.-based healthcare companies positioned to reduce disparities in underserved communities and scale toward a potentially successful exit. If your company fits that profile, we want to hear from you.

Contact Business Development

Healthcare Partners

If you are a payor, hospital, health system, or governmental agency that services rural, tribal, or other complex underserved populations, we would welcome the opportunity to share existing solutions we have identified or to use our network to source new solutions for the problems these communities face.